Our Mission

At Enlivity our mission is to improve the oral and digestive health of patients going through cancer treatment. 

Company Stage: Seed
(seeking investment)

About Us

Enlivity is a medical nutrition company founded by Gillian Isabelle, Ph.D to help cancer patients get better by focusing on the human side of treatment.

When a loved one is diagnosed with cancer, we tend to focus on schedules, plans, and statistics, while forgetting about quality of life. Maintaining quality of life and managing side effects are important parts of cancer treatment. Side effects can get in the way of daily activities, and in severe cases, they can even affect treatment schedule. This is why at Enlivity, our goal is to help make treatment side effects better by providing patients with affordable, easy-to-use products that are over the counter.

Because so many cancer treatment side effects occur in the mouth and the gastrointestinal tract, our products focus on food and nutrient-based solutions. Absorbing the right nutrients, when and where you need it, can help minimize complications and alleviate side effects.

Committed to Science-Based Solutions

We partner with expert oncology healthcare providers to develop science-based nutrient solutions that treat more than the symptoms. Our first product, Healios®, was formulated by hematologist-oncologist Dr. Peter Anderson, MD, Ph.D to help support normal cell repair along the gastrointestinal (GI) tract of patients with mouth sores or who have difficulty swallowing due to chemotherapy or radiation.

Helping Those Who Need It Most

We are dedicated to supporting patients, so they can continue needed treatments with minimal clinical complications and hospitalizations. Through the generous support of our manufacturing partner, we are able to offer one (1) Healios® unit for free to patients under the age of 18 who are most likely to develop mouth sores and have difficulty swallowing.

Healios for children, pediatric patients

Our Team

Gillian Isabelle, PhD

Founder and Chief Executive Officer


For over 15 years, Dr. Isabelle has focused her career at the intersection of science and business, leading multi-disciplinary teams and building collaborative partnerships to advance early-stage technologies towards commercialization. Prior to founding Enlivity, Dr. Isabelle served as the Founding Director of the Business Development Office at the Broad Institute of MIT and Harvard, where she led negotiations that resulted in over $75 million in industry funding.

Dr. Isabelle has also worked with PureTech Health, a venture creation firm in Boston, where she served on the executive management team for several startup companies. In that capacity, she worked alongside the company CEOs to develop technology and business strategies, direct R&D efforts and raise funding from investors. In addition, she spent 10 years with Corning, Inc, first in product development in telecommunications (for which she was awarded a US patent), and later in business development in the Life Sciences division. Dr. Isabelle received her bachelor’s and doctoral degrees from MIT, and her master’s degree from the University of California, Berkeley, all in Materials Science and Engineering.

Jill Tobacco, MPH, RD Enlivity Chief Marketing Officer

Jill Tobacco, MPH, RD

Co-Founder and Chief Marketing Officer


Jill brings more than 20 years of experience in brand marketing and communications. She has led integrated brand and product marketing initiatives for high-profile brands, non-profit organizations and government agencies. Before co-founding Enlivity, Jill served as the Director of Marketing and Communications at DentaQuest. There she led all B2B campaigns targeting health plans nationwide and was responsible for member outreach to more than 20 million members across the country. Jill has also worked for several other companies and agencies, including Weber Shandwick Worldwide where Jill led national and market-specific product and health/wellness campaigns for clients including Odwalla, Hormel, The Coca-Cola Company, Eggland’s Best Eggs, Ocean Spray and Novartis.

In addition to her extensive marketing experience, Jill also has a background in public health and nutrition. She worked as a clinical dietitian and public health nutritionist at hospitals, community-based organizations, and state government institutions. Jill received her BS in Nutritional Science from California State Polytechnic University, San Luis Obispo; and her MPH in Nutrition from the University of California, Berkeley.

Shawna Vogel, MBA

Chief Operating Officer


Shawna brings more than 15 years of leadership experience in healthcare, higher education, and consulting. Her areas of expertise include operations, strategic planning, partnership development, alliance and client management. Prior to joining Enlivity, Shawna served as the Director of Grants and Contract Administration at MIT’s Office of Sponsored Programs (OSP). There she led a 25+ person team, streamlined operations to absorb volume growth via multiple process improvements, and became a two time recipient of the OSP Director Award. Shawna also served as the Executive Director of the Center for Regenerative Medicine (CRM) at MGH where she operationalized CRM’s mission and oversaw the expansion of their multimillion-dollar fiscal portfolio.

In addition to her extensive operations experience, Shawna also has a background in business development and alliance management. At MGH, and in her preceding role at MIT’s Technology Licensing Office, Shawna fostered national and international alliances and negotiated contracts with startups, biotechs, pharmaceutical companies, foundations, hospitals and universities. Shawna also founded a consulting firm focused on new product launch plans, business plans for startups, and strategies for structuring and negotiating industry-university partnerships. Shawna received her BS in Biology from MIT, and her MBA from Babson College where she graduated magna cum laude.

Mary Beth

Mary Beth Lisman, Esq.

Legal Counsel 


Mary Beth is the founder of a private legal practice representing clients ranging from independent entrepreneurs, private-equity portfolio companies and multinational corporations in all aspects of legal affairs. Mary Beth has counseled clients in a vast array of industries including software development, bio-tech, life sciences, online and digital media and e-media, event management, and B2B publishing. She is recognized as an effective accessible legal counselor and business partner for diversified management teams as well as their professional advisors and strategic partners.

In the course of her practice, Mary Beth has drafted and negotiated multi-million-dollar strategic alliances, joint ventures, software development, licensing and vendor agreements, as well as build-to-suit commercial leases. She has drafted and negotiated first and second series financing terms for several startups in an array of industries and has been an advisor to several start-up ventures. Mary Beth has acted as a senior legal advisor in over 50 completed and numerous proposed acquisitions and divestitures. In additional to her experience with commercial contract negotiations and financing arrangements, Mary Beth has authored and negotiated domestic and international intellectual property licensing agreements and has advised clients on all areas of trademark and copyright enforcement and infringement prosecution. Mary Beth earned a BA from Boston College and a JD from Suffolk University Law School.  

Shemifhar Freytes, MSE

Business Development and Marketing Operations


Shemi is a well-rounded business professional with a diverse background in life science, tech, marketing, operations, corporate culture, and entrepreneurship. She is passionate about merging science and technology in ways that help make a difference in patients’ lives.  Over the last 10 years she has worked for large and small companies in laboratory and business projects.

Prior to joining Enlivity, Shemi worked for AGTC, a gene therapy company dedicated to developing cures for rare blinding conditions. There she led special projects alongside of the CEO, CFO, and CBO related to the company’s research programs, marketing, public relations, and operations. Shemi has also worked with Novartis, The Broad institute of MIT and Harvard, and Boston University in technology integration and process development. She holds a bachelor’s degree in Molecular Biology & Genetics from Boston University and a Master of Science in Entrepreneurship from the University of Florida, where she was also the recipient of the Thomas S. Johnson Entrepreneurial Scholar Award.


Peter Anderson, MD, Ph.D

Scientific Advisor and Board Member


Dr. Anderson is an experienced and dedicated physician with over 35 years of experience. He is currently a Staff Physician at the Cleveland Clinic, and previously served as the Curtis Distinguished Professor and Section Chief of non-neural solid tumors in the Department of Pediatrics Patient Care at The University of Texas MD Anderson Cancer Center. Dr. Anderson also practiced at the Mayo Clinic, where he launched the pediatric bone marrow transplant program.

Dr. Anderson specializes in Pediatric Hematology-Oncology and has published more than 120 peer-reviewed publications. He has served as principal investigator in numerous clinical studies, including two very large osteosarcoma and Ewing sarcoma immunotherapy trials. In the 1990’s, Dr. Anderson discovered the benefits of glutamine supplementation in the management of cancer treatment toxicities in the mouth, throat and esophagus. During this time, he developed Healios®, a glutamine based dietary supplement that can help patients with mouth sores or who have difficulty swallowing due to chemotherapy or radiation.

Jason Walsh, MBA

Financial Advisor


Mr. Walsh has over 20 years of experience in finance and business development. He has served as an executive playing major roles in the success and development of startup life science companies, emerging biotechnology firms, and large pharmaceutical companies.   

In addition to his extensive corporate experience, Mr. Walsh co-founded two life science ventures, Provenance Biopharmaceutical Corp. and Wisdom Biosciences Corp. He currently serves as managing partner at Great Rock Biotech, a boutique consulting firm providing finance, operations, and strategy consulting to early stage life science companies. Mr. Walsh received his MBA from Babson College, and his B.S. in Management from the University of Massachusetts.

Bob Jones, MBA

Business Advisor and Board Member 


Mr. Jones is a leader in the medical nutrition sector, currently serving as the CEO of Scientific Nutrition Products, Inc., his fourth Boston-based startup. Mr. Jones previously launched three other medical nutrition companies, working in areas such as diabetes and weight management. These companies were formed in partnerships with staff and faculty of the Harvard Medical School and led to consumer products that were sold through retail pharmacies. Additionally, Mr. Jones has served as CEO of Vitasoy USA (a management turn-around), while he worked as principal in a strategy consulting firm. He also held sales and marketing positions at Abbott Laboratories and Baxter International. Mr. Jones earned an A.B. in biology (cum laude) from Princeton University, and an MSM (MBA + thesis) from MIT Sloan.

We’d love to hear from you!